A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population

Nature Genetics

Volumn 38, Issue 8, 2006, Pages 921-925

  Ozaki, Kouichi ^a   Sato, Hiroshi ^b   Iida, Aritoshi ^a   Mizuno, Hiroya ^b   Nakamura, Takahiro ^a   Miyamoto, Yoshinari ^a   Takahashi, Atsushi ^a   Tsunoda, Tatsuhiko ^a   Ikegawa, Shiro ^a   Kamatani, Naoyuki ^a   Hori, Masatsugu ^b   Nakamura, Yusuke ^a   Tanaka, Toshihiro ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEASOME 20S; PROTEIN SUBUNIT; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC GROUP; EXON; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC RISK; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; HUMAN CELL; INFLAMMATION; JAPAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; PSMA6 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UBIQUITINATION;

ALLELES; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL LINE; EXONS; GENE FREQUENCY; HAPLOTYPES; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; RISK FACTORS; RNA, SMALL INTERFERING;

EID: 33746555366     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1846     Document Type: Article

References (30)

1. Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
2. Yamada, Y. et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347, 1916-1923 (2002).
3. Ozaki, K. et al. Functional SNPs in the lymphotoxin-a gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654 (2002).
4. Wang, L., Fan, C., Topol, S.E., Topol, E.J. & Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578-1581 (2003).
5. Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233-239 (2004).
6. Ozaki, K. et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-a secretion in vitro. Nature 429, 72-75 (2004).
7. Cipollone, F. et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. J. Am. Med. Assoc. 291, 2221-2228 (2004).
8. Pajukanta, P. et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67, 1481-1493 (2000).
9. Broeckel, U. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210-214 (2002).
10. Harrap, S.B. et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22, 874-878 (2002).
11. Wang, Q. et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74, 262-271 (2004).
12. Hauser, E.R. et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75, 436-447 (2004).
13. Samani, N.J. et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77, 1011-1020 (2005).
14. Karin, M. & Delhase, M. The IkB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol. 12, 85-98 (2000).
15. Maki, C.G., Huibregtse, J.M. & Howley, P.M. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56, 2649-2654 (1996).
16. Salghetti, S.E., Kim, S.Y., & Tansey, W P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726 (1999).
17. Dimmeler, S., Breitschopf, K., Haendeler, J. & Zeiher, A.M. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189, 1815-1822 (1999).
18. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
19. Beinke, S. & Ley, S.C. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem. J. 382, 393-409 (2004).
20. Coux, O., Tanaka, K. & Goldberg, A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847 (1996).
21. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
22. Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. & Tanaka, T Gene-based SNP discover as part of the Japanese Millennium Genome project: identification of 190,562 genetic variations in the human genome. J. Hum. Genet. 47, 605-610 (2002).
23. Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004).
24. Lo, H.S. et al. Allelic variation in gene expression is common in the human genome. Genome Res. 13, 1855-1862 (2003).
25. Herrmann, J., Ciechanover, A., Lerman, L.O. & Lerman, A. The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended. Cardiovasc. Res. 61, 11-21 (2004).
26. Meiners, S. et al. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 105, 483-489 (2002).
27. Pye, J. et al. Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 284, H919-H926 (2003).
28. Elliott, P.J., Zollner, T.M. & Boehncke, W.H. Proteasome inhibition: a new antiinflammatory strategy. J. Mol. Med. 81, 235-245 (2003).
29. Pritchard, J.K. & Rosenberg, N.A. Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65, 220-228 (1999).
30. den Dunnen, J.T. & Antonarakis, S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 15, 7-12 (2000).